Literature DB >> 23055349

Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.

F Loria1, G Loria, S Basile, G Crea, D Randazzo, L Frosina.   

Abstract

The aim of this study was to evaluate and correlate the enhancement pattern of hepatocellular carcinoma (HCC) on contrast-enhanced ultrasound (CEUS) and tumour cellular differentiation on histopathology. Patients underwent hepatic CEUS, performed with SonoVue and contrast pulse sequencing. The correlation between enhancement time and enhancement level of the lesions in different vascular phases and tumour cellular differentiation was determined. The tumours were graded according to the Edmondson grading system. Then, diagnosis was obtained by histopathological examination following surgery or percutaneous ultrasound-guided biopsy. 189 patients with HCC were examined with CEUS and histopathological examination between 2003 and 2009: 159 had a solitary lesion (85 %), 24 had 2 lesions (12 %) and 6 had multiple lesions (3 %). The final histological grading of the tumours was as follows: 22, 114, 49, 4 grade I-IV, respectively. Significant differences were shown between the time that HCC become hypoenhancing or remained echogenic in late phase and tumour cellular differentiation (p = 0.006, p = 0.036). The timing of HCC becoming hypoenhancing was correlated with tumour cellular differentiation, with better differentiated HCCs washing out more slowly than poorly differentiated ones (p = 0.164, p = 0.113; p = 0.186, p = 0.070). The enhancement pattern of HCC by CEUS correlates with the cellular differentiation. In late phases, hyperechoic lesions are likely to be better differentiated, whereas hypoechoic lesion is more likely to be poorly differentiated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055349     DOI: 10.1007/s13304-012-0179-7

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  36 in total

1.  Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules.

Authors:  H Honda; T Tajima; K Taguchi; T Kuroiwa; K Yoshimitsu; H Irie; H Aibe; K Shinozaki; Y Asayama; M Shimada; K Masuda
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

Authors:  Emilio Quaia; Fabrizio Calliada; Michele Bertolotto; Sandro Rossi; Lorena Garioni; Laura Rosa; Roberto Pozzi-Mucelli
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

4.  Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.

Authors:  Carlos Nicolau; Violeta Catalá; Ramón Vilana; Rosa Gilabert; Luis Bianchi; Manel Solé; Mario Pagés; Concepció Brú
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

5.  Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).

Authors:  A von Herbay; C Vogt; J Westendorff; D Häussinger; M Gregor
Journal:  Ultraschall Med       Date:  2009-12-07       Impact factor: 6.548

Review 6.  Ultrasound of focal liver masses.

Authors:  Hisham Tchelepi; Philip W Ralls
Journal:  Ultrasound Q       Date:  2004-12       Impact factor: 1.657

7.  Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation.

Authors:  K Takayasu; Y Muramatsu; H Furukawa; F Wakao; N Moriyama; T Takayama; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

8.  Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients.

Authors:  C Reinhold; L Hammers; C R Taylor; C L Quedens-Case; C K Holland; K J Taylor
Journal:  AJR Am J Roentgenol       Date:  1995-05       Impact factor: 3.959

9.  Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis.

Authors:  N Rahbin; A-K Siösteen; A Elvin; L Blomqvist; K Hagen; R Hultcrantz; S Aleman
Journal:  Acta Radiol       Date:  2008-04       Impact factor: 1.990

10.  Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.

Authors:  Hui-Xiong Xu; Xiao-Yan Xie; Ming-De Lu; Guang-Jian Liu; Zuo-Feng Xu; Yan-Lin Zheng; Jin-Yu Liang; Li-Da Chen
Journal:  J Clin Ultrasound       Date:  2008-06       Impact factor: 0.910

View more
  6 in total

1.  Ultrasonic diagnosis combined with targeted ultrasound contrast agent improves diagnostic sensitivity of ultrasonic for non-small cell lung cancer patients.

Authors:  Xiaohong Zhang; Can Xiao
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

2.  Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.

Authors:  Wei Wu; Minhua Chen; Kun Yan; Yin Dai; Shanshan Yin; Wei Yang; Zhihui Fan
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

3.  Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors.

Authors:  Wen-Tao Kong; Zheng-Biao Ji; Wen-Ping Wang; Hao Cai; Bei-Jian Huang; Hong Ding
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

4.  Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.

Authors:  Dan Yang; Rui Li; Xiao-Hang Zhang; Chun-Lin Tang; Kuan-Sheng Ma; De-Yu Guo; Xiao-Chu Yan
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

5.  Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver.

Authors:  Peihua Wang; Fang Nie; Tiantian Dong; Dan Yang; Ting Liu; Guojuan Wang
Journal:  Diagnostics (Basel)       Date:  2021-12-01

6.  Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions.

Authors:  Ke Lv; Hongyan Zhai; Yuxin Jiang; Ping Liang; Hui-Xiong Xu; Lianfang Du; Yi-Hong Chou; Xiaoyan Xie; YuKun Luo; Young Joon Lee; Jae Young Lee; Bing Hu; Baoming Luo; Yi Wang; Ying Luan; Christina Kalli; Kun Chen; Wenping Wang; Ja-Der Liang
Journal:  Abdom Radiol (NY)       Date:  2021-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.